Welcome to LookChem.com Sign In|Join Free
  • or
5-Amino-3-methyl-4-isoxazolecarbonitrile, a heterocyclic organic compound with the molecular formula C5H5N3O and a molecular weight of 127.12 g/mol, is characterized by the presence of an isoxazole ring, a cyano group, and an amino group. This versatile chemical serves as a building block in the synthesis of pharmaceuticals and agricultural chemicals, and is also utilized in the development of new materials and chemical research. Its potential biological activity has garnered interest in medicinal chemistry for possible therapeutic applications.

35261-01-9

Post Buying Request

35261-01-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

35261-01-9 Usage

Uses

Used in Pharmaceutical Industry:
5-Amino-3-methyl-4-isoxazolecarbonitrile is used as a key building block in the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its unique structure and functional groups enable its incorporation into diverse molecular frameworks, enhancing the pharmacological properties and therapeutic potential of the resulting compounds.
Used in Agricultural Chemical Industry:
In the agricultural chemical industry, 5-amino-3-methyl-4-isoxazolecarbonitrile serves as a crucial component in the synthesis of various agrochemicals, including pesticides and herbicides. Its incorporation into these compounds can improve their efficacy, selectivity, and environmental compatibility, contributing to more sustainable agricultural practices.
Used in Material Science:
5-Amino-3-methyl-4-isoxazolecarbonitrile is utilized in the development of new materials, such as polymers, coatings, and composites, due to its versatile chemical properties and reactivity. Its incorporation into these materials can enhance their performance, durability, and functionality, leading to innovative applications in various industries.
Used in Chemical Research:
As a subject of interest in chemical research, 5-amino-3-methyl-4-isoxazolecarbonitrile is employed in the exploration of new chemical reactions, synthesis methods, and mechanistic insights. Its unique structure and reactivity provide a valuable platform for understanding fundamental chemical processes and developing novel synthetic strategies.
Used in Medicinal Chemistry:
5-Amino-3-methyl-4-isoxazolecarbonitrile is recognized for its potential biological activity and is a subject of interest in medicinal chemistry for its potential therapeutic applications. Its incorporation into drug candidates can modulate their pharmacological properties, such as potency, selectivity, and bioavailability, leading to the discovery of new treatments for various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 35261-01-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,2,6 and 1 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 35261-01:
(7*3)+(6*5)+(5*2)+(4*6)+(3*1)+(2*0)+(1*1)=89
89 % 10 = 9
So 35261-01-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H5N3O/c1-3-4(2-6)5(7)9-8-3/h7H2,1H3

35261-01-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Amino-3-methylisoxazole-4-carbonitrile

1.2 Other means of identification

Product number -
Other names 5-amino-3-methyl-1,2-oxazole-4-carbonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:35261-01-9 SDS

35261-01-9Relevant academic research and scientific papers

Pyrimidine ring-containing substituted five-membered heterocyclic compound as well as preparation method and application thereof

-

Paragraph 0335-0338, (2021/02/06)

The invention discloses a substituted five-membered heterocyclic compound containing pyrimidine rings. The structure is shown in a formula I: (the formula I is shown in the description), and the definition of each substation group is shown in the descript

Pyrimidine-containing fused heterocyclic compounds, and preparation method and application thereof

-

Paragraph 0266-0269, (2020/04/17)

The invention discloses pyrimidine-containing fused heterocyclic compounds, and a preparation method and application thereof. The structures of the pyrimidine-containing fused heterocyclic compounds are as shown in a general formula I which is described in the specification. In the general formula I, each substituent group is as defined in the specification. The compounds provided by the inventionhave broad-spectrum bactericidal activity, and have excellent prevention and treatment effects on cucumber downy mildew, wheat powdery mildew and the like.

Substituted six-membered heterocyclic compound containing pyrimidine rings and preparation method and application thereof

-

Paragraph 0357-0360, (2018/06/04)

The invention discloses a substituted six-membered heterocyclic compound containing pyrimidine rings. The structure is shown in a formula I: (the formula I is shown in the description), and the definition of each substation group is shown in the description. The substituted six-membered heterocyclic compound has the advantages that the broad-spectrum bacteria-killing and insect-killing activity isrealized; the good preventing and controlling effect is realized for cucumber downy mildew, wheat powdery mildew, puccinia polysora, rice blast, cucumber anthracnose and the like; meanwhile, the goodinsect-killing activity is realized.

HCV INHIBITING BI-CYCLIC PYRIMIDINES

-

Page/Page column 29, (2010/10/20)

The present invention relates to the use of bi-cyclic pyrimidines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates to processes for pre

Bicyclicpyrimidones and their use to treat diseases

-

, (2008/06/13)

The present invention is directed to dihydropyrimidones having formula I or II and methods of using them to induce mitotic arrest, thereby making them useful as anti-cancer agents and other diseases that can be treated by inducing mitotic arrest.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 35261-01-9